MAPK3 and ovarian cancer: As represented by the flow cytometry histograms, pERK1/2 expression in the DMSO control (untreated) was increased in comparison to the negative control (PE FMO control) and overlaid with the positive control (activated), reflecting the known phosphorylation of ERK1/2 in ovarian cancer.42